MEILLEURHEALTH (02327) plans to sell Australian properties to Executive Director Zhou Wenchuan
Meirui Health International (02327) announced that on January 10, 2025, the company's indirect wholly-owned subsidiary U-Ho...
MEILLEUREHEALTH (02327) announced that on January 10, 2025, its indirect wholly-owned subsidiary, U-Home Oceania Pty Ltd, intends to sell the property to the company's Executive Director and CEO, Ms. Zhou Wenchuan, for 1.36 million Australian dollars. The property is located at Lot 6, 100 La Trobe Avenue, Alphington, VIC, 3078, Australia.
The group is mainly engaged in residential and commercial real estate business. The Australian residential development project will develop 109 townhouse units, which are currently being pre-sold in batches. Ms. Zhou Wenchuan has subscribed to one of the units. The Board believes that the sale will accelerate the realization of the group's land reserves and/or property values, generating additional operating funds to strengthen the group's liquidity and financial position. The company intends to use the net proceeds from the sale to supplement the group's operating funds.
Related Articles

Following closely in the footsteps of Trump's visit to the UK, Alphabet Inc. Class C (GOOGL.US) plans to invest 5 billion pounds to support the development of AI in the UK.

HK Stock Market Move | JIAXIN INTL RES(03858) rises by over 6% as tungsten prices remain strong. The company's core asset is the Baktun Tungsten Mine.

Huachuang Securities: Maintains a "buy" rating on JXR (01951) with a target price of HK$3.23.
Following closely in the footsteps of Trump's visit to the UK, Alphabet Inc. Class C (GOOGL.US) plans to invest 5 billion pounds to support the development of AI in the UK.

HK Stock Market Move | JIAXIN INTL RES(03858) rises by over 6% as tungsten prices remain strong. The company's core asset is the Baktun Tungsten Mine.

Huachuang Securities: Maintains a "buy" rating on JXR (01951) with a target price of HK$3.23.
